Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
French telecommunications specialist Invoxia is taking its expertise in the human GPS space into the companion animal market.
Credo Biomedical is looking for series B investment to further the development its lead diagnostic product.
California-based Ark Animal Health began work on establishing a companion animal therapeutics portfolio in 2014. After five years, the company is readying the launch of its resiniferatoxin candidate. Animal Pharm analyst Daniel Willis spoke to Ark president Alexis Nahama at the recent Animal Health Investment Europe forum in London about the company's future plans.
German pet nutritional supplement specialist Purapep has a seed funding round and series A in its sights over the next two years.
Idaho-based pet medication supplier PetIQ believes the companion animal market in the US is set for healthy growth, despite the cost of medicine to owners proving to be a constant obstacle. Animal Pharm editor Joseph Harvey examined this dynamic and spoke to pricing specialist Graham Tatham of consultancy Simon-Kucher & Partners' animal health practice for his point-of-view.
Bayer Animal Health will stimulate even further growth from its Seresto flea and tick collar after introducing the product to the Chinese market.
Last month, animal health's newest billion-dollar business – Covetrus – was created and launched on the Nasdaq. Animal Pharm editor Joseph Harvey spoke to the company's president and chief executive Ben Shaw about his roots in animal health and the change Covetrus can bring to the wider veterinary sector.
At the recent Animal Health Investment Europe forum in London, Animal Pharm editor Joseph Harvey led a panel discussion on digital personalization in pet care. He spoke to three companies in this area – Fitbark, Antelliq and Felcana. Below is an excerpt of the panel discussion.
Zoetis is seeking an additional European approval for Stronghold Plus under a different brand name.
MSP[RS] Resistant Starch is seeking partners to take its prebiotic to new species, such as companion animals.
Washington-based pharmaceutical company Vivos has reported promising results in recent trials aimed at tackling canine soft tissue sarcoma using a hydrogel treatment.
Cindy Cole is providing New York City-based investment firm Digitalis Ventures with key insights into the veterinary sector and animal health industry.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.